T2 Biosystems Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:TTOO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
13 Sep 24SellUS$133David ElsbreeIndividual55US$2.42

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TTOO?
Owner TypeNumber of SharesOwnership Percentage
Public Companies1,2110.00575%
Individual Insiders1,021,1604.85%
Hedge Funds1,396,0006.63%
Institutions1,510,6127.18%
General Public6,435,99630.6%
VC/PE Firms10,677,97350.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 419.5%.


Top Shareholders

Top 25 shareholders own 69.41% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
50.7%
CR Group L.P.
10,677,973US$4.5m0%100.0%
6.63%
Armistice Capital LLC
1,396,000US$593.3k-15.8%0.01%
4.75%
Jacob Safier
1,000,000US$425.0k0%no data
3.59%
New Dimensions Trading Ltd., Asset Management Arm
755,000US$320.9k0%100.0%
1.86%
The Vanguard Group, Inc.
390,368US$165.9k24.8%no data
0.43%
Geode Capital Management, LLC
90,880US$38.6k-30.3%no data
0.37%
BlackRock, Inc.
76,827US$32.7k-1.88%no data
0.3%
State Street Global Advisors, Inc.
63,743US$27.1k0%no data
0.22%
Susquehanna International Group, LLP, Asset Management Arm
45,481US$19.3k9.16%no data
0.19%
Millennium Management LLC
39,140US$16.6k0%no data
0.13%
Northern Trust Global Investments
27,142US$11.5k-30.2%no data
0.095%
Jason Carrick
20,000US$8.5k0%no data
0.07%
Goldman Sachs Group, Investment Banking and Securities Investments
14,750US$6.3k0.31%no data
0.019%
Royal Bank of Canada, Banking & Securities Investments
4,001US$1.7k40.1%no data
0.011%
Tower Research Capital Europe Limited
2,399US$1.0k-68.7%no data
0.0057%
Canon Inc.
1,211US$514.20%no data
0.0019%
John Sperzel
400US$169.90%no data
0.0015%
Carson Wealth Management Group
310US$131.50%no data
0.0014%
Group One Trading LP, Asset Management Arm
289US$122.5-71.4%no data
0.00095%
Advisor Group Holdings, Inc., Asset Management Arm
200US$85.00%no data
0.00067%
John Sprague
141US$59.90%no data
0.00064%
Michael Gibbs
135US$57.20%no data
0.00048%
Barclays Bank PLC, Securities Investments
101US$42.90%no data
0.0004%
Seymour E. Liebman
85US$35.80%no data
0.00037%
Brett Giffin
77US$33.10%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/29 02:45
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

T2 Biosystems, Inc. is covered by 10 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Benjamin HaynorAlliance Global Partners
Karen KoskiBTIG
Kyle MiksonCanaccord Genuity